Retail Investors Gain Direct Access to SpaceX IPO via Robinhood Fidelity and Charles Schwab JPMorgan Adjusts HPQ Price Target Ahead of Upcoming Earnings Report Dow Jones Hits Record High as Middle East Hopes Lift Wall Street Sentiment European Reindustrialisation Faces Funding Challenge Amid AI Investment Surge Kazatomprom Posts 17 Production Jump in Q3 Boosting Uranium Supply Outlook The Secretive and Lucrative World of Orchid Breeding A DecadeLong Investment Revolve Group RVLV Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Martin Marietta Materials MLM Q1 2026 Earnings EPS Nearly Meets Estimates Despite Headwinds Acacia Research Corporation ACTG Q1 2026 Earnings Significant EPS Miss Amidst Uncertain Revenue Landscape WKHS Q1 2026 Earnings Deepening Losses Amid Operational Transition Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain EXP Q1 2026 Earnings Powerful EPS Beat Highlights Cost Discipline Amid Subdued Demand AMREP Corporation AXR Edges Higher as Shares Test Near Resistance Celldex Therapeutics CLDX Edges Lower Amid Consolidation Near Key Support BioAge Labs BIOA Jumps 46 as Biotech Momentum Drives Price Toward Key Resistance FGI Industries Tumbles 497 Tests Critical Support Zone LG Display ADR LPL Slides Nearly 10 as Support Levels Come into Focus US Consumer Sentiment Remains Gloomy Amid Persistent Inflation Geopolitical Tensions and Trade Policy Uncertainty Siebert Financial Corp SIEB Q4 2025 Earnings A Narrow Loss Amid Quiet Trading Atlanta Braves Holdings BATRK Edges Higher as Support Holds Steady Investors Title Company ITIC Edges Down as Support Levels Come Into Focus Firefly Aerospace FLY Surges 1881 on Strong Volume and Sector Tailwinds Kratos Defense Security Solutions KTOS Extends Gains Defense Sector Momentum Lifts Stock to 5520 Interparfums IPAR Gains 26 as Price Approaches Key Resistance Level Cadrenal Therapeutics CVKD Slides 52 as Support Level Comes into Focus Hackett Group HCKT Posts Modest Gains Amid Consolidation Range Cabaletta Bio Holds Steady CABA Stock Rises Slightly Amid Biotech Volatility